Literature DB >> 9359082

Molecular targets for the rational design of antiepileptic drugs and related neuroprotective agents.

Z Lin1, P K Kadaba.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9359082     DOI： 10.1002/(sici)1098-1128(199711)17:6<537::aid-med3>3.0.co;2-2

Source DB:  PubMed          Journal:  Med Res Rev        ISSN： 0198-6325            Impact factor:   12.944


× No keyword cloud information.
  5 in total

1.  Novel fused 1,2,3-triazolo-benzodiazepine derivatives as potent anticonvulsant agents: design, synthesis, in vivo, and in silico evaluations.

Authors:  Arefeh Shafie; Maryam Mohammadi-Khanaposhtani; Mehdi Asadi; Nastaran Rahimi; Parviz Rashidi Ranjbar; Jahan B Ghasemi; Bagher Larijani; Mohammad Mahdavi; Hamed Shafaroodi; Ahmad Reza Dehpour
Journal:  Mol Divers       Date:  2019-03-20       Impact factor: 2.943

2.  Anticonvulsant profiles of certain new 6-aryl-9-substituted-6,9-diazaspiro-[4.5]decane-8,10-diones and 1-aryl-4-substituted-1,4-diazaspiro[5.5]undecane-3,5-diones.

Authors:  Mohamed N Aboul-Enein; Aida A El-Azzouny; Mohamed I Attia; Yousreya A Maklad; Mona E Aboutabl; Fatma Ragab; Walaa H A Abd El-Hamid
Journal:  Int J Mol Sci       Date:  2014-09-23       Impact factor: 5.923

3.  Synthesis and Anticonvulsant Activity Evaluation of 3-alkoxy-4-(4-(hexyloxy/heptyloxy)phenyl)-4H-1,2,4 -triazole.

Authors:  Ying-Quan Fang; Chun-Ling Sun; Da-Chuan Liu; Shi-Ben Wang; Zhe-San Quan
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

4.  Anticonvulsant potential of certain new (2E)-2-[1-Aryl-3-(1H-imidazol-1-yl)propylidene]-N-(aryl/H)hydrazinecarboxamides.

Authors:  Mohamed I Attia; Mohamed N Aboul-Enein; Aida A El-Azzouny; Yousreya A Maklad; Hazem A Ghabbour
Journal:  ScientificWorldJournal       Date:  2014-01-12

Review 5.  Recent developments on triazole nucleus in anticonvulsant compounds: a review.

Authors:  Ming-Xia Song; Xian-Qing Deng
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.